文献速递脑血管病外科

阿司匹林与颅内动脉瘤生长率降低相关

Aspirin associated with decreased rate of intracranial aneurysm growth.
PubMed 文献 · J Neurosurg · 2019-10-29

该回顾性研究纳入146例多发颅内动脉瘤(IAs)患者共375个动脉瘤,观察未治疗的229个≤5mm动脉瘤的生长情况。中位随访至少5年,24个(10.48%)动脉瘤生长。多因素分析显示阿司匹林与动脉瘤生长率降低显著相关(OR 0.19,95%CI 0.05-0.63)。

要点

  • 阿司匹林与多发小动脉瘤生长率降低独立相关(OR 0.19)。
  • 高血压、药物滥用、多囊肾病和蛛网膜下腔出血增加生长风险。
  • 观察期间无动脉瘤破裂,生长动脉瘤均接受治疗。

核心结论

  • 在多发性颅内动脉瘤患者中,阿司匹林显著降低动脉瘤随时间生长的速率。

研究设计与样本

  • 回顾性分析2009年7月至2019年1月前瞻性维护数据库,纳入146例多发IAs患者,共375个动脉瘤,其中229个(2-5mm)观察生长,随访至少5年。

主要发现

  • 229个观察动脉瘤中24个(10.48%)生长,均后续接受治疗,无破裂。
  • 多因素分析显示阿司匹林与生长率降低相关(OR 0.19,95%CI 0.05-0.63)。
  • 高血压(OR 14.38,95%CI 3.83-53.94)、药物滥用(OR 11.26,95%CI 1.21-104.65)、多囊肾病(OR 9.48,95%CI 1.51-59.35)和蛛网膜下腔出血(OR 5.91,95%CI 1.83-19.09)与生长率增加相关。

临床怎么用

  • 对于多发小动脉瘤(≤5mm)患者,阿司匹林可能作为延缓动脉瘤生长的潜在策略,但需个体化评估。

局限性

  • 回顾性设计,需前瞻性干预研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Aspirin has emerged as a potential agent in the prevention of rupture of intracranial aneurysms (IAs). In this study, the authors' goal was to test if aspirin is protective against aneurysm growth in patients harboring multiple IAs ≤ 5 mm. METHODS: The authors performed a retrospective review of a prospectively maintained database covering the period July 2009 through January 2019. Patients' data were included if the following criteria were met: 1) the patient harbored multiple IAs; 2) designated primary aneurysms were treated by surgical/endovascular means; 3) the remaining aneurysms were observed for growth; and 4) a follow-up period of at least 5 years after the initial treatment was available. Demographics, earlier medical history, the rupture status of designated primary aneurysms, aneurysms' angiographic features, and treatment modalities were gathered. RESULTS: The authors identified 146 patients harboring a total of 375 IAs. At the initial encounter, 146 aneurysms were treated and the remaining 229 aneurysms (2-5 mm) were observed. During the follow-up period, 24 (10.48%) of 229 aneurysms grew. All aneurysms observed to grow later underwent treatment. None of the observed aneurysms ruptured. Multivariate analysis showed that aspirin was significantly associated with a decreased rate of growth (odds ratio [OR] 0.19, 95% confidence interval [CI] 0.05-0.63). Variables associated with an increased rate of growth included hypertension (OR 14.38, 95% CI 3.83-53.94), drug abuse (OR 11.26, 95% CI 1.21-104.65), history of polycystic kidney disease (OR 9.48, 95% CI 1.51-59.35), and subarachnoid hemorrhage at presentation (OR 5.91, 95% CI 1.83-19.09). CONCLUSIONS: In patients with multiple IAs, aspirin significantly decreased the rate of aneurysm growth over time. Additional prospective interventional studies are needed to validate these findings.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Zanaty M, Roa JA, Nakagawa D, et al. Aspirin associated with decreased rate of intracranial aneurysm growth. J Neurosurg. 2019. PMID: 31662579. doi:10.3171/2019.6.JNS191273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。